ACAD
Acadia Pharma (ACAD)
NASDAQ
$20.31+$0.11 (+0.57%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $3.5B
    Market Cap
  • -5.61%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 84
Valuation
ACAD
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 24
Valuation
ACAD
vs History
vs S&P 500
3-Month Momentum
3.85%
12-Month Momentum
24.17%
3-Month Risk Adjusted Momentum
25.04%
12-Month Risk Adjusted Momentum
69.85%

True Yield

N/A
Valuation
ACAD
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 64
Valuation
ACAD
vs History
vs S&P 500
Ohlson's O-Score
10